AZN - AstraZeneca to test Breztri in reduction of cardiopulmonary events
2024-03-13 11:55:57 ET
More on AstraZeneca
- 5 Reasons AstraZeneca Stock Can Rise In 2024
- AstraZeneca PLC (AZN) Q4 2023 Earnings Call Transcript
- AstraZeneca FY23 Earnings Review: It's OK To Buy Dip On Q4 Bottom Line Miss
- FDA experts recommend changes to flu shots
- Pfizer, Gilead, Roche seen benefitting the most from antibody-drug conjugates